(ESLT) Elbit Systems - Ratings and Ratios
Unmanned Aerial, Electro-Optic, C4ISR, Electronic Warfare, Armored Vehicles
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.47% |
| Yield on Cost 5y | 2.16% |
| Yield CAGR 5y | 4.61% |
| Payout Consistency | 89.3% |
| Payout Ratio | 25.2% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 36.5% |
| Value at Risk 5%th | 56.3% |
| Relative Tail Risk | -6.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.35 |
| Alpha | 116.11 |
| CAGR/Max DD | 2.45 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.307 |
| Beta | 0.219 |
| Beta Downside | 0.201 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.43% |
| Mean DD | 6.06% |
| Median DD | 5.14% |
Description: ESLT Elbit Systems December 17, 2025
Elbit Systems Ltd. (NASDAQ:ESLT) designs, manufactures, and integrates airborne, land, and naval defense solutions for a global customer base that includes the U.S. military, foreign military sales programs, homeland-security agencies, and commercial aviation operators.
The firm operates through five segments-Aerospace; C4I & Cyber; ISTAR & Electronic Warfare; Land; and Elbit Systems of America (ESA)-offering a breadth of products such as unmanned aerial systems, precision-guided-munition sensors, electro-optical lasers, cyber-intelligence platforms, and survivability kits for armored vehicles.
Key metrics from FY 2023 show revenue of roughly $5.9 billion, an operating margin near 9 %, and an order backlog exceeding $8.5 billion, reflecting strong demand driven by rising U.S. defense appropriations (≈4 % YoY growth) and Israel’s sustained defense-spending target of ~3 % of GDP. The global shift toward autonomous and network-centric warfare further underpins growth prospects for Elbit’s UAV and C4ISR portfolios.
For a deeper dive into valuation multiples and peer comparison, the ValueRay database offers a concise snapshot.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (463.6m TTM) > 0 and > 6% of Revenue (6% = 470.2m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 4.17pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 22.96% (prev 12.44%; Δ 10.51pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 913.1m > Net Income 463.6m (YES >=105%, WARN >=100%) |
| Net Debt (923.8m) to EBITDA (800.5m) ratio: 1.15 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (47.7m) change vs 12m ago 6.84% (target <= -2.0% for YES) |
| Gross Margin 24.23% (prev 23.89%; Δ 0.34pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 67.88% (prev 60.51%; Δ 7.37pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.14 (EBITDA TTM 800.5m / Interest Expense TTM 151.7m) >= 6 (WARN >= 3) |
Altman Z'' 2.42
| (A) 0.15 = (Total Current Assets 7.42b - Total Current Liabilities 5.62b) / Total Assets 12.24b |
| (B) 0.22 = Retained Earnings (Balance) 2.74b / Total Assets 12.24b |
| (C) 0.05 = EBIT TTM 627.9m / Avg Total Assets 11.54b |
| (D) 0.34 = Book Value of Equity 2.82b / Total Liabilities 8.23b |
| Total Rating: 2.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.96
| 1. Piotroski 5.50pt |
| 2. FCF Yield 3.02% |
| 3. FCF Margin 9.40% |
| 4. Debt/Equity 0.27 |
| 5. Debt/Ebitda 1.15 |
| 6. ROIC - WACC (= 6.62)% |
| 7. RoE 12.77% |
| 8. Rev. Trend 88.19% |
| 9. EPS Trend 72.90% |
What is the price of ESLT shares?
Over the past week, the price has changed by +11.79%, over one month by +21.30%, over three months by +15.16% and over the past year by +119.81%.
Is ESLT a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ESLT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 534.6 | -6.7% |
| Analysts Target Price | 534.6 | -6.7% |
| ValueRay Target Price | 828.3 | 44.6% |
ESLT Fundamental Data Overview December 16, 2025
P/E Trailing = 52.3618
P/S = 3.1215
P/B = 5.9538
P/EG = 2.21
Beta = -0.385
Revenue TTM = 7.84b USD
EBIT TTM = 627.9m USD
EBITDA TTM = 800.5m USD
Long Term Debt = 249.6m USD (from longTermDebt, last quarter)
Short Term Debt = 345.5m USD (from shortTermDebt, last quarter)
Debt = 1.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 923.8m USD (from netDebt column, last quarter)
Enterprise Value = 24.43b USD (24.10b + Debt 1.07b - CCE 733.3m)
Interest Coverage Ratio = 4.14 (Ebit TTM 627.9m / Interest Expense TTM 151.7m)
FCF Yield = 3.02% (FCF TTM 736.7m / Enterprise Value 24.43b)
FCF Margin = 9.40% (FCF TTM 736.7m / Revenue TTM 7.84b)
Net Margin = 5.92% (Net Income TTM 463.6m / Revenue TTM 7.84b)
Gross Margin = 24.23% ((Revenue TTM 7.84b - Cost of Revenue TTM 5.94b) / Revenue TTM)
Gross Margin QoQ = 24.89% (prev 23.97%)
Tobins Q-Ratio = 2.00 (Enterprise Value 24.43b / Total Assets 12.24b)
Interest Expense / Debt = 3.28% (Interest Expense 35.0m / Debt 1.07b)
Taxrate = 7.86% (11.6m / 147.2m)
NOPAT = 578.5m (EBIT 627.9m * (1 - 7.86%))
Current Ratio = 1.32 (Total Current Assets 7.42b / Total Current Liabilities 5.62b)
Debt / Equity = 0.27 (Debt 1.07b / totalStockholderEquity, last quarter 4.00b)
Debt / EBITDA = 1.15 (Net Debt 923.8m / EBITDA 800.5m)
Debt / FCF = 1.25 (Net Debt 923.8m / FCF TTM 736.7m)
Total Stockholder Equity = 3.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.79% (Net Income 463.6m / Total Assets 12.24b)
RoE = 12.77% (Net Income TTM 463.6m / Total Stockholder Equity 3.63b)
RoCE = 16.18% (EBIT 627.9m / Capital Employed (Equity 3.63b + L.T.Debt 249.6m))
RoIC = 13.28% (NOPAT 578.5m / Invested Capital 4.36b)
WACC = 6.66% (E(24.10b)/V(25.16b) * Re(6.82%) + D(1.07b)/V(25.16b) * Rd(3.28%) * (1-Tc(0.08)))
Discount Rate = 6.82% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 3.35%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈522.0m ; Y1≈342.7m ; Y5≈156.7m
Fair Price DCF = 66.42 (DCF Value 3.08b / Shares Outstanding 46.4m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 72.90 | EPS CAGR: 7.43% | SUE: 1.44 | # QB: 7
Revenue Correlation: 88.19 | Revenue CAGR: 7.35% | SUE: -0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.00 | Chg30d=N/A | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=13.92 | Chg30d=-0.167 | Revisions Net=+0 | Growth EPS=+15.2% | Growth Revenue=+11.6%
Additional Sources for ESLT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle